Monday, 5 October 2015

Cuba Crude Oil Refinery Outlook to 2020: Market Research, Insights, outlook and survey report

“Cuba Crude Oil Refinery Outlook to 2020” is a comprehensive report on crude oil refinery industry in Cuba. The report provides oil production, consumption, exports and imports details from 2000 to 2020 along with oil reserves for the period 2000 to 2014. The report also provides details on oil refineries such as name, type, operational status, operator apart from capacity data for the major processing units, for all active and planned refineries in Cuba till 2020. Further, the report also offers recent developments, financial deals as well as latest contracts awarded in the countrys oil refinery industry.


Scope

- Historic and forecast of oil data related to production, consumption, imports and exports for the period 2000–2020, and reserves for the period 2000–2014

- Updated information related to all active and planned refineries in the country, including operator and equity details

- Information on CDU, condensate splitter, coking, FCC and hydrocracking capacities by refinery in the country, where available

- Key mergers and acquisitions, partnerships, private equity and IPOs in the countrys crude oil industry, where available

- Latest developments and awarded contracts related to crude oil refineries in the country


Reasons to buy

- Gain a strong understanding of the countrys energy sector and crude oil refining industry

- Facilitate decision making on the basis of strong historic and forecast production, reserves and capacity data

- Assess your competitors major crude oil refining assets and their performance in the country

- Analyze the latest developments and awarded contracts related to the countrys crude oil refining industry

- Understand the countrys financial deals landscape by analyzing how competitors are financed, and the mergers and partnerships that have shaped the market


For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at No comments:

Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2015

Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2015" provides an overview of Acute Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database — Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=386135

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months


Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse All Reports in Pharmaceutical Category @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

List of Tables 4

List of Figures 5

Introduction 6

Acute Spinal Cord Injury 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials in E7 Countries by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Unaccomplished Trials of Acute Spinal Cord Injury 24

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Acute Spinal Cord Injury Therapeutics Clinical Trials 30

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at No comments:

Prurigo Global Clinical Trials Review, H2, 2015 Industry Key Trends, Size, Growth, Shares And Forecast Research Report

Prurigo Global Clinical Trials Review, H2, 2015" provides an overview of Prurigo clinical trials scenario. This report provides top line data relating to the clinical trials on Prurigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database — Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=386138

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months


Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse All Reports in Pharmaceutical Category @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

List of Tables 4

List of Figures 5

Introduction 6

Prurigo 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Prurigo to Dermatology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by Phase 17

In Progress Trials by Phase 18

Clinical Trials by Trial Status 19

Clinical Trials by End Point Status 20

Unaccomplished Trials of Prurigo 21

Subjects Recruited Over a Period of Time 22

Clinical Trials by Sponsor Type 23

Prominent Sponsors 24

Top Companies Participating in Prurigo Therapeutics Clinical Trials 25

Prominent Drugs 26

Clinical Trial Profiles 27

Clinical Trial Overview of Top Companies 27

GlaxoSmithKline Plc 27

Clinical Trial Overview of GlaxoSmithKline Plc 27

Trevi Therapeutics, Inc. 28

Clinical Trial Overview of Trevi Therapeutics, Inc. 28

Velocity Pharmaceutical Development 29

Clinical Trial Overview of Velocity Pharmaceutical Development 29

Tigercat Pharma, Inc. 30

Clinical Trial Overview of Tigercat Pharma, Inc. 30

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at No comments:

Skin Rash Global Clinical Trials Review, H2, 2015 Industry Key Trends, Size, Growth, Shares And Forecast Research Report

Skin Rash Global Clinical Trials Review, H2, 2015" provides an overview of Skin Rash clinical trials scenario. This report provides top line data relating to the clinical trials on Skin Rash. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database — Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=386141

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months


Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse All Reports in Pharmaceutical Category @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

List of Tables 4

List of Figures 5

Introduction 6

Skin Rash 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Skin Rash to Dermatology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Skin Rash to Dermatology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Skin Rash 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Skin Rash Therapeutics Clinical Trials 30

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at No comments:

Hand Dermatitis Global Clinical Trials Review, H2, 2015

Hand Dermatitis Global Clinical Trials Review, H2, 2015" provides an overview of Hand Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hand Dermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database — Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=386144

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months


Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse All Reports in Pharmaceutical Category @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

List of Tables 4

List of Figures 5

Introduction 6

Hand Dermatitis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Hand Dermatitis to Dermatology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Hand Dermatitis to Dermatology Clinical Trials 17

Clinical Trials by Phase 18

Clinical Trials by Trial Status 19

Clinical Trials by End Point Status 20

Unaccomplished Trials of Hand Dermatitis 21

Subjects Recruited Over a Period of Time 22

Clinical Trials by Sponsor Type 23

Prominent Sponsors 24

Top Companies Participating in Hand Dermatitis Therapeutics Clinical Trials 25

Prominent Drugs 26

Clinical Trial Profiles 27

Clinical Trial Overview of Top Companies 27

Basilea Pharmaceutica AG 27

Clinical Trial Overview of Basilea Pharmaceutica AG 27

GlaxoSmithKline Plc 28

Clinical Trial Overview of GlaxoSmithKline Plc 28

Omega Pharma NV 29

Clinical Trial Overview of Omega Pharma NV 29

Nuvo Research Inc. 30

Clinical Trial Overview of Nuvo Research Inc. 30

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at No comments:

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2015

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2015" provides an overview of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Urticaria Pigmentosa (Mastocytosis, Mastocytoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database — Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=386147

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months


Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse All Reports in Pharmaceutical Category @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

List of Tables 4

List of Figures 5

Introduction 6

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials in E7 Countries by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Subjects Recruited Over a Period of Time 24

Clinical Trials by Sponsor Type 25

Prominent Sponsors 26

Top Companies Participating in Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials 27

Prominent Drugs 28

Clinical Trial Profiles 29

Clinical Trial Overview of Top Companies 29

C. H. Boehringer Sohn AG & Co. KG 29

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 29

Novartis AG 30

Clinical Trial Overview of Novartis AG 30

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at No comments:

Thursday, 1 October 2015

Global Li-ion battery market to grow at a CAGR of 11.9% during 2014–2019

About Li-ion Batteries
Li-ion batteries are extensively used in consumer electronics such as cell phones, smartphones, laptops, and tablets because of their reliability in terms of performance compared to other battery types. High energy density and a low self-discharge rate and maintenance have made Li-ion batteries more popular than other rechargeable batteries. The application base of these batteries is widening and expected to encompass EVs, medical devices, power tools, and ESS. Growing demand for EVs and ESS worldwide bodes well for the overall growth prospects of the market. The market will continue to expand, driven by the growing use of smartphones, laptops, and tablets globally.

Technavio's analysts forecast the global Li-ion battery market to grow at a CAGR of 11.9% during 2014-2019.

Covered in this Report
The report covers the present scenario and the growth prospects of the global Li-ion battery market for 2015-2019. The market has been segmented on the basis of geography and application.


Technavio's report, Global Li-ion Battery Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
Americas 
APAC
EMEA

Key Vendors 
A123 Systems
AESC
Blue Energy
BYD
China BAK Battery
Coslight
GS Yuasa
Hitachi
Johnson Controls
Kokam
LG Chem
Li-Tec
NEC
Panasonic
Samsung SDI
SK Innovation
Sony
Tianjin Lishen Battery
Toshiba
Toshiba Other Prominent Vendors


ATL
Boston Power
Cell-Con
CNEBIKES
Ecsem
Electrovaya
Enerdel
Hhnel Industries
Highpower International
HYB Battery
KAYO
Lenmar Enterprises
Minamoto
Shenzhen Blazepower Battery
Shenzhen Jixinglong
ShenZhen Sun Rise Digital
Sunwoda

Key Market Driver
Decreasing Cost of Li-ion Batteries
For a full, detailed list, view our report

Key Market Challenge
Rise in Li-ion Battery Prices due to Pollution Concerns in China
For a full, detailed list, view our report

Key Market Trend
Growing Li-ion Battery Production in China
For a full, detailed list, view our report

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at No comments:
Subscribe to: Posts (Atom)